HIV Prevention in SA Needs Local Lenacapavir Manufacturing

HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Tagged Africa CDC, Aspen Pharmacare, HIV Prevention, HIV South Africa, lenacapavir, Local Manufacturing, PrEP, Project Africa First, SAHPRA, WHO Pre-Qualification